Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy: a survey among Dutch rheumatologists

Article Abstract:

Etanercept and infliximab are found to be effective in treating patients suffering from ankylosing spondylitis. A test is conducted to see if such patients can start the tumor necrosis factor (TNF) blocking therapy.

Author: Landewe, R., Rump, B., Heijde, D. van der, Linden, S. van der
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2004
Evaluation, Etanercept

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: A histopathological study on the effect of infliximab on rheumatoid nodules

Article Abstract:

The impact of infliximab on the immunopathology of rheumatoid nodules is discussed. Six patients with rheumatoid arthritis are examined, the treatments and results of which are explained.

Author: Baeten, D., Keyser, F. De, Veys, E. M., Theate, Y., Houssiau, F. A., Durez, P.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2004
Rheumatoid arthritis, Joint diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

Article Abstract:

The study results on the effectiveness and safety of infliximab in the treatment of ankylosing spondylitis are presented.

Author: Sieper, J., Braun, J., Schneider, M., Zeidler, H., Brandt, J., Listing, J., Zink, A., Alten, R., Burmester, G., Gromnica-Ihle, E., Kellner, H., Sorensen, H.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2005
Germany, Complications and side effects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Research, United States, Dosage and administration, Tumor necrosis factor, Ankylosing spondylitis, Tumour necrosis factor, Infliximab
Similar abstracts:
  • Abstracts: Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes
  • Abstracts: VX-680, a potent and selective small-molecule inhibitor of the Aurora-kinases, suppresses tumor growth in vivo
  • Abstracts: Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirs
  • Abstracts: Safety issues involving medical devices: Implications of recent implantable cardioverter-difibrillator malfunctions
  • Abstracts: APHA sections find success in fundraising efforts. Family Van staff on front lines of fighting health disparities
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.